A Stacked Multimodality Model Based on Functional MRI Features and Deep Learning Radiomics for Predicting the Early Response to Radiotherapy in Nasopharyngeal Carcinoma

Background: This study aimed to construct and assess a comprehensive model that integrates MRI-derived deep learning radiomics, functional imaging (fMRI), and clinical indicators to predict early efficacy of radiotherapy in nasopharyngeal carcinoma (NPC).

Methods: This retrospective study recruited NPC patients with radiotherapy from two Chinese hospitals between October 2018 and July 2022, divided into a training set (hospital I, 194 cases), an internal validation set (hospital I, 82 cases), and an external validation set (hospital II, 40 cases). We extracted 3404 radiomic features and 2048 deep learning features from multi-sequence MRI includes T1WI, CE-T1WI, T2WI and T2WI/FS. Additionally, both the Apparent diffusion coefficient (ADC), its maximum (ADCmax) and Tumor blood flow (TBF), its maximum (TBFmax) were obtained by Diffusion-weighted imaging (DWI) and Arterial spin labeling (ASL) respectively. We used four classifiers (LR, XGBoost, SVM and KNN) and stacked algorithm as model construction methods. The area under the receiver operating characteristic curve (AUC) and decision curve analysis was used to assess models.

Results: The manual radiomics model based on XGBoost and the deep learning model based on KNN (the AUCs in the training set: 0.909, 0.823, respectively) showed better predictive efficacy than other machine learning algorithms. The stacked model that integrated MRI-based deep learning radiomics, fMRI, and hematological indicators, has the strongest efficacy prediction ability of AUC in the training set [0.984 (95%CI: 0.972-0.996)], the internal validation set [0.936 (95%CI: 0.885-0.987)], and the external validation set [0.959 (95%CI: 0.901-1.000)].

Conclusion: Our research has developed a clinical-radiomics integrated model based on MRI which can predict early radiotherapy response in NPC and provide guidance for personalized treatment.